Pancreatic Cancer Research

ResearcherSeoul National UniversityNo recent work listed

Joon Koo Han

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-5916-5545; OpenAlex author ID A5040976081. Sources: OpenAlex.

Their work

Papers
16 (first author 0, last author 8)
Trials
0
Grants
0
Labs led
1
Collaborators
31
Papers, trials and grants by year

2011: 1 paper · 2012: 1 paper · 2013: 2 papers · 2014: 1 paper · 2015: 1 paper · 2016: 2 papers · 2017: none · 2018: 1 paper · 2019: 2 papers · 2020: 1 paper · 2021: 3 papers · 2022: 1 paper

Papers 16

  1. Prediction of residual tumor and overall survival after first-line surgery in patients with pancreatic ductal adenocarcinoma using preoperative magnetic resona… Last author DOI 10.1177/0284185121999998↗
  2. Predictors of conversion surgery in patients with pancreatic cancer who underwent neoadjuvant or palliative FOLFIRINOX treatment using baseline and follow-up C… Last author DOI 10.1007/s00261-021-03127-3↗
  3. Important CT and histopathological findings for recurrence and overall survival in patients with pancreatic ductal adenocarcinoma who underwent surgery after n… Last author DOI 10.1007/s00330-020-07489-y↗
  4. Preoperative assessment of the resectability of pancreatic ductal adenocarcinoma on CT according to the NCCN Guidelines focusing on SMA/SMV branch invasion. Co-author DOI 10.1007/s00330-021-07847-4↗
  5. Synergistic Effects of Pulsed Focused Ultrasound and a Doxorubicin-Loaded Microparticle-Microbubble Complex in a Pancreatic Cancer Xenograft Mouse Model. Last author DOI 10.1016/j.ultrasmedbio.2020.07.019↗
  6. CT prediction of resectability and prognosis in patients with pancreatic ductal adenocarcinoma after neoadjuvant treatment using image findings and texture ana… Last author DOI 10.1007/s00330-018-5574-0↗
  7. MDCT findings predicting post-operative residual tumor and survival in patients with pancreatic cancer. Last author DOI 10.1007/s00330-019-06140-9↗
  8. Magnetic resonance with diffusion-weighted imaging improves assessment of focal liver lesions in patients with potentially resectable pancreatic cancer on CT. Last author DOI 10.1007/s00330-017-5258-1↗
  9. Pancreatic neuroendocrine tumour (PNET): Staging accuracy of MDCT and its diagnostic performance for the differentiation of PNET with uncommon CT findings from… Co-author DOI 10.1007/s00330-015-3941-7↗
  10. Therapeutic Effects of Microbubbles Added to Combined High-Intensity Focused Ultrasound and Chemotherapy in a Pancreatic Cancer Xenograft Model. Co-author DOI 10.3348/kjr.2016.17.5.779↗
  11. Differential diagnosis of pancreatic cancer from other solid tumours arising from the periampullary area on MDCT. Co-author DOI 10.1007/s00330-015-3721-4↗
  12. Dynamic contrast-enhanced ultrasonographic (DCE-US) assessment of the early response after combined gemcitabine and HIFU with low-power treatment for the mouse… Co-author DOI 10.1007/s00330-014-3260-4↗
  13. Pulsed high-intensity focused ultrasound enhances apoptosis of pancreatic cancer xenograft with gemcitabine. Co-author DOI 10.1016/j.ultrasmedbio.2013.06.004↗
  14. Diagnostic performance of MDCT for predicting important prognostic factors in pancreatic cancer. Co-author DOI 10.1097/mpa.0b013e318287c604↗
  15. Magnetic resonance imaging findings of the mass-forming type of autoimmune pancreatitis: comparison with pancreatic adenocarcinoma. Co-author DOI 10.1002/jmri.23609↗
  16. Concurrent chemotherapy and pulsed high-intensity focused ultrasound therapy for the treatment of unresectable pancreatic cancer: initial experiences. Last author DOI 10.3348/kjr.2011.12.2.176↗

Closest collaborators

The 25 strongest of 31 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Jung Hoon Kim · 10 shared papers, 2012–2022 · strength 1.06
  2. Ijin Joo · 7 shared papers, 2012–2021 · strength 0.76
  3. Sae‐Jin Park · 3 shared papers, 2021 · strength 0.50
  4. Jae Seok Bae · 2 shared papers, 2019–2022 · strength 0.35
  5. Hyo‐Jin Kang · 2 shared papers, 2020–2022 · strength 0.34
  6. Jae Young Lee · 6 shared papers, 2011–2020 · strength 0.34
  7. Dong Ho Lee · 2 shared papers, 2018–2021 · strength 0.22
  8. Jin‐Young Jang · 2 shared papers, 2018–2021 · strength 0.22
  9. Su Joa Ahn · 2 shared papers, 2018–2019 · strength 0.19
  10. Eun-Joo Park · 2 shared papers, 2016–2020 · strength 0.18
  11. Bo Ram Kim · 2 shared papers, 2016–2019 · strength 0.17
  12. Jeong Min Lee · 3 shared papers, 2012–2016 · strength 0.14
  13. Hongbeom Kim · 1 shared paper, 2021 · strength 0.13
  14. Haeryoung Kim · 1 shared paper, 2021 · strength 0.13
  15. Kyoung-Bun Lee · 1 shared paper, 2021 · strength 0.13
  16. Wooil Kwon · 1 shared paper, 2021 · strength 0.13
  17. Byung Ihn Choi · 3 shared papers, 2012–2016 · strength 0.13
  18. Byung Ihn Choi · 3 shared papers, 2011–2015 · strength 0.13
  19. Byung‐Ihn Choi · 2 shared papers, 2014–2016 · strength 0.12
  20. Hak Jong Lee · 1 shared paper, 2020 · strength 0.12
  21. Yun Deok Ahn · 1 shared paper, 2020 · strength 0.12
  22. Seo‐Youn Choi · 1 shared paper, 2019 · strength 0.11
  23. Sun Kyung Jeon · 1 shared paper, 2018 · strength 0.08
  24. Hyun Kyung Yang · 1 shared paper, 2018 · strength 0.08
  25. Mi Hye Yu · 1 shared paper, 2016 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.